STOCK TITAN

MariMed Inc. (OTCQB: MRMD) COO converts RSUs and adjusts stock holdings

(Neutral)
(Neutral)
Form Type
4

Rhea-AI Filing Summary

MariMed Inc. reports that COO Timothy Shaw exercised 42,656 RSUs into common stock and had 14,781 shares withheld to satisfy tax obligations related to the vesting. After these transactions, he holds 9,426,904 shares directly and 127,969 RSUs, plus 2,000,000 shares held in an irrevocable family trust for his children, for which he disclaims beneficial ownership.

Positive

  • None.

Negative

  • None.
Insider Shaw Timothy
Role Chief Operating Officer
Type Security Shares Price Value
Exercise Restricted Stock Units (RSU) 42,656 $0.00 --
Exercise Common stock 42,656 $0.00 --
Tax Withholding Common stock 14,781 $0.0662 $978.50
holding Common stock -- -- --
Holdings After Transaction: Restricted Stock Units (RSU) — 127,969 shares (Direct); Common stock — 9,426,904 shares (Direct); Common stock — 2,000,000 shares (Indirect, By the Shaw Family Trust)
Footnotes (1)
  1. RSUs convert to shares of common stock on a one-for-one basis. Reflects shares of common stock withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting of RSUs. The Reporting Person's spouse is the trustee of the trust and the shares held in the trust are for the benefit of the Reporting Person's children. The trust is an irrevocable trust. The Reporting Person disclaims beneficial ownership of these securities, and the filing of this report is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose. The RSUs were granted on April 15, 2026; the remaining RSUs under this grant will vest in three equal installments on each of October 15, 2026, January 15, 2027 and April 15, 2027, in accordance with the terms of an award agreement between the Issuer and the Reporting Person.
RSUs converted to common stock 42,656 shares Common stock acquired on 2026-07-15 via RSU conversion (code M)
Shares withheld for taxes 14,781 shares Shares of common stock withheld to satisfy tax withholding obligations on RSU vesting
Direct common shares after transactions 9,426,904 shares Total MariMed common stock held directly by Timothy Shaw following 2026-07-15 transactions
Remaining RSU position 127,969 RSUs Restricted Stock Units reported as outstanding after the RSU conversion on 2026-07-15
Shares held in family trust 2,000,000 shares Common stock held by the Shaw Family Trust; beneficial ownership disclaimed by Timothy Shaw
Tax withholding price $0.0662 per share Per-share value used for 14,781 shares withheld to satisfy tax obligations
Restricted Stock Units (RSU) financial
"Security title "Restricted Stock Units (RSU)" with underlying common stock"
tax withholding obligations financial
"Shares of common stock withheld by the Issuer to satisfy tax withholding obligations"
irrevocable trust financial
"The trust is an irrevocable trust and holds shares for the Reporting Person's children"
An irrevocable trust is a legal arrangement where an owner transfers assets into a separate entity managed by a trustee and gives up the power to modify or reclaim those assets. For investors it matters because putting stock or other holdings into such a trust can change who controls and benefits from the assets, affect taxes and creditor protection, and influence how easy it is to sell or value those holdings—like placing valuables in a locked safe overseen by someone else.
beneficial ownership regulatory
"The Reporting Person disclaims beneficial ownership of these securities"
Beneficial ownership means the person or entity that actually enjoys the benefits of owning shares or other assets — such as receiving dividends, voting rights, or price gains — even if the legal title is held in another name. For investors it matters because knowing who truly controls and profits from a company reveals who can influence decisions, exposes potential conflicts of interest or hidden concentration of power, and affects transparency and risk in the stock.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates

FAQ

What insider equity transactions did MariMed (MRMD) COO Timothy Shaw report?

Timothy Shaw exercised 42,656 RSUs into common stock and had 14,781 shares withheld for taxes. These July 15, 2026 transactions left him with 9,426,904 MariMed shares held directly and 127,969 RSUs reported as outstanding.

How many MariMed (MRMD) shares does Timothy Shaw hold after the reported transactions?

Timothy Shaw reports 9,426,904 MariMed shares held directly after the transactions. He also reports 127,969 RSUs outstanding and 2,000,000 shares held in an irrevocable family trust for his children, for which he disclaims beneficial ownership.

What is the RSU vesting schedule disclosed for MariMed (MRMD) COO Timothy Shaw?

The RSUs were granted on April 15, 2026, with remaining units vesting in three installments. Vesting dates are October 15, 2026, January 15, 2027, and April 15, 2027, under an award agreement between MariMed and Shaw.

How are the Shaw Family Trust’s MariMed (MRMD) shares characterized in the filing?

The Shaw Family Trust holds 2,000,000 MariMed shares as an irrevocable trust for Shaw’s children. Shaw’s spouse is trustee, and he expressly disclaims beneficial ownership of these securities for Section 16 or any other purpose.
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Shaw Timothy

(Last)(First)(Middle)
C/O MARIMED INC.
10 OCEANA WAY

(Street)
NORWOOD, MASSACHUSETTS 02062

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
MARIMED INC. [ MRMD ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director10% Owner
XOfficer (give title below)Other (specify below)
Chief Operating Officer
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
07/15/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common stock07/15/2026M42,656A$0(1)9,426,904D
Common stock07/15/2026F14,781(2)D$0.06629,412,123D
Common stock2,000,000IBy the Shaw Family Trust(3)
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Restricted Stock Units (RSU)(1)07/15/2026M42,656 (4) (4)Common Stock, par value $.001 per share42,656$0127,969D
Explanation of Responses:
1. RSUs convert to shares of common stock on a one-for-one basis.
2. Reflects shares of common stock withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting of RSUs.
3. The Reporting Person's spouse is the trustee of the trust and the shares held in the trust are for the benefit of the Reporting Person's children. The trust is an irrevocable trust. The Reporting Person disclaims beneficial ownership of these securities, and the filing of this report is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.
4. The RSUs were granted on April 15, 2026; the remaining RSUs under this grant will vest in three equal installments on each of October 15, 2026, January 15, 2027 and April 15, 2027, in accordance with the terms of an award agreement between the Issuer and the Reporting Person.
Remarks:
/s/ Timothy Shaw07/15/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)